Krystal Biotech Inc
F:4KB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Krystal Biotech Inc
F:4KB
|
US |
|
U
|
UPM-Kymmene Oyj
DUS:RPL
|
FI |
|
Kweichow Moutai Co Ltd
SSE:600519
|
CN |
|
P
|
Panasonic Holdings Corp
XMUN:MAT1
|
JP |
|
V
|
Visa Inc
F:3V64
|
US |
|
B
|
BROOKFIELD ASSET MANAGEMENT LTD
TSX:BAM
|
CA |
|
S
|
SoftBank Group Corp
DUS:SFT
|
JP |
|
W
|
Wheaton Precious Metals Corp
XMUN:SII
|
CA |
|
Grindrod Ltd
OTC:GRDLY
|
ZA |
|
P
|
Performance Food Group Co
F:P5F
|
US |
|
N
|
Nintendo Co Ltd
LSE:0R1E
|
JP |
|
Brinks Co
NYSE:BCO
|
US |
|
R
|
Ryanair Holdings PLC
XMUN:RY4C
|
IE |
Bankruptcy Probability
Krystal Biotech Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Krystal Biotech Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Krystal Biotech Inc
NASDAQ:KRYS
|
10B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
470.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
226.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
188.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
133.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
78.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
87.1B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
59.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
43.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Krystal Biotech Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Krystal Biotech Inc has no debt.
You can find a full breakdown on its Balance Sheet.